Healthcare costs to drop as new GST rate begins Sep 22: Pharma industry

Medicines, including some life saving drugs, and medical devices are set to become cheaper from Monday with the new GST rates kicking in, making healthcare more affordable and accessible for every citizen, according to industry players.

With the landmark GST reforms announced by Prime Minister Narendra Modi come into effect from September 22, it will make healthcare more affordable and accessible for every citizen, Indian Pharmaceutical Alliance Secretary General Sudarshan Jain said.

“Most medicines, earlier taxed at 12 per cent, will now attract just 5 per cent GST. In addition, 36 critical life-saving drugs for cancer, genetic and rare diseases, and cardiovascular conditions have been fully exempted,” he added.

Also Read: MCD launches new system to ease licence application process for industrial 

The GST Council has also rationalised tax slabs on health and life insurance premiums, glucometers, and corrective spectacles, Jain said.

“These measures mark a transformative shift in India’s healthcare landscape, delivering direct savings to patients, easing the burden on families, improving access to essential care, and strengthening healthcare security,” he added.

Jain further said, “The Indian Pharmaceutical Alliance (IPA), representing 23 leading research-driven companies, is fully committed to ensuring these benefits reach citizens swiftly and transparently, advancing our mission of affordable and accessible healthcare for all.”

Earlier, Organisation of Pharmaceutical Producers of India (OPPI) Director General Anil Matai had stated that the decision to reduce GST on lifesaving medicines — bringing 33 essential drugs from 12 per cent tax slab to nil and three critical drugs for cancer, rare diseases, and other severe chronic conditions from 5 per cent to nil — is both historic and compassionate.

Also read: Pedestrians older than 40 are at the greatest risk on roads, suggests Traffic Police data

The bold step will significantly reduce the financial strain on patients and families and make healthcare more affordable and accessible at every level — from hospitals to households, he said.

Similarly, NATHEALTH President, and Executive Chairperson, Metropolis Healthcare Ltd, Ameera Shah also noted that by easing costs and improving affordability, the measure will enhance access to quality healthcare services, support early disease detection, and bring greater consistency by standardising GST rates across preventive, curative and rehabilitative care.”